Shareholders Filed a Lawsuit Against RxSight for Overstating Demand

Court: C.D. California

Case: 2:25-cv-01596

On July 22, 2025, RXST shareholders have filed a class action against RxSight, accusing it of overstating demand for its intraocular lens system and concealing internal challenges that led to poor financial results and the abrupt resignation of its CFO.

What is this lawsuit about?

On July 15, 2025, RxSight reported Q2 2025 results that missed expectations, slashed its full-year revenue guidance by over $25 million, and announced the immediate resignation of its CFO. Following this, RXST fell a combined 58.5%, including 32.5% on July 15 and 26% on July 16.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify RXST investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.